ArticleInvestigational new drugs2025

Safety and efficacy of semi-dose venetoclax plus azacitidine in unfit acute myeloid leukemia patients in China: a real-world single-center study.

Xian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.